// App-Quantinova.ai

44 : Hydroxychloroquine-induced Cardiomyopathy Presenting as Heart Failure

Researchers

Presenter

  • Gina Rohekar

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Left ventricular hypertrophy

  • Rheumatoid arthritis

  • Dyspnea

  • Pulmonary edema

  • Heart muscle disease

  • Cardiotoxicity

  • Congestive heart failure

  • Fabry disease

  • Angina

  • Inflammatory Arthritis

  • Cap myopathy

  • Syncope

Biomarkers

  • N/A

Drug/Treatment

  • Albyl-E

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • Angiotensin II

Outcome

  • Positive


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final